BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33595329)

  • 1. Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues.
    Hammid A; Fallon JK; Lassila T; Salluce G; Smith PC; Tolonen A; Sauer A; Urtti A; Honkakoski P
    Mol Pharm; 2021 Mar; 18(3):1305-1316. PubMed ID: 33595329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues.
    Hammid A; Fallon JK; Lassila T; Vieiro P; Balla A; Gonzalez F; Urtti A; Smith PC; Tolonen A; Honkakoski P
    Drug Metab Dispos; 2022 Dec; 50(12):1483-1492. PubMed ID: 36195336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
    Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
    Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
    Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
    Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.
    Gabriele M; Puccini P; Gervasi PG; Longo V
    Life Sci; 2021 Jul; 277():119486. PubMed ID: 33864822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esterase activity in porcine and albino rabbit ocular tissues.
    Heikkinen EM; Del Amo EM; Ranta VP; Urtti A; Vellonen KS; Ruponen M
    Eur J Pharm Sci; 2018 Oct; 123():106-110. PubMed ID: 30030098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase.
    Shimizu M; Fukami T; Nakajima M; Yokoi T
    Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology.
    Nagaoka M; Sakai Y; Nakajima M; Fukami T
    Biochem Pharmacol; 2024 May; 223():116128. PubMed ID: 38492781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA.
    Fu J; Sadgrove M; Marson L; Jay M
    Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans.
    Honda S; Fukami T; Hirosawa K; Tsujiguchi T; Zhang Y; Nakano M; Uehara S; Uno Y; Yamazaki H; Nakajima M
    Drug Metab Dispos; 2021 Sep; 49(9):718-728. PubMed ID: 34135089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase.
    Yasuda K; Watanabe K; Fukami T; Nakashima S; Ikushiro SI; Nakajima M; Sakaki T
    Drug Metab Pharmacokinet; 2021 Aug; 39():100397. PubMed ID: 34171773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
    Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver.
    Kobayashi Y; Fukami T; Shimizu M; Nakajima M; Yokoi T
    Drug Metab Dispos; 2012 Jun; 40(6):1080-4. PubMed ID: 22446520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
    Thomsen R; Rasmussen HB; Linnet K;
    Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC.
    Honda S; Fukami T; Tsujiguchi T; Zhang Y; Nakano M; Nakajima M
    Eur J Pharm Sci; 2021 Jun; 161():105807. PubMed ID: 33722734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight on porcine carboxylesterases expression and activity in lung tissues.
    Cavallero A; Donadel G; Puccini P; Gervasi PG; Gabisonia K; Longo V; Gabriele M
    Res Vet Sci; 2024 Aug; 175():105314. PubMed ID: 38823354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
    Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
    Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog.
    Kurokawa T; Fukami T; Yoshida T; Nakajima M
    Drug Metab Dispos; 2016 Mar; 44(3):409-16. PubMed ID: 26718653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety].
    Imai T
    Yakugaku Zasshi; 2007 Apr; 127(4):611-9. PubMed ID: 17409690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.